Picture of Gamida Cell logo

GMDAQ — Gamida Cell News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

U.S. STOCKS ON THE MOVE-Obseva, Walgreens, Zoom

* 
      Eikon search string for individual stock moves:  STXBZ 
    

        * 
      The Day Ahead newsletter: https://refini.tv/3LI4BU7
    

        * 
      The Morning News Call newsletter: https://refini.tv/3dKUyB8
    

  
U.S. stock index futures were trading flat on Tuesday after starting the week
lower due to worries around stricter COVID-19 curbs in China, while drawing
comfort from less-hawkish comments on interest-rate hikes from policymakers.
 .N 
    At 7:06 a.m. ET, Dow e-minis  1YMc1  were up 0.14% at 33,781. S&P 500
e-minis  ESc1  were up 0.10% at 3,962, while Nasdaq 100 e-minis  NQc1  were down
0.06% at 11,581.5.
    The top three NYSE percentage gainers premarket  .PRPG.NQ :
    ** Gaotu Techedu Inc  GOTU.N , up 14.2%
    ** Venator Materials  VNTR.N , up 8.1%
    ** Avaya Holdings Corp  AVYA.N , up 6.7%
    The top three NYSE percentage losers premarket  .PRPL.NQ :
    ** Kaleyra Inc  KLR.N , down 8.5%
    ** Perfect Corp  PERF.N , down 7%
    ** Carpenter Technology Corp  CRS.N , down 4.9%
    The top Nasdaq percentage gainer premarket  .PRPG.O :
    ** Obseva SA  OBSV.O , up 52.9%
    The top two Nasdaq percentage losers premarket  .PRPL.O :
    ** Gamida Cell Ltd  GMDA.O , down 19.1%
    ** Ebang International Holdings Inc  EBON.O , down 16.2%
    ** Zoom Video Communications Inc  ZM.O : down 9.3% premarket
    BUZZ - Drops on annual revenue forecast cut  urn:newsml:reuters.com:*:nL4N32I2A4 
    ** Obseva SA  OBSV.O : up 52.9% premarket
    BUZZ - Surges on license sale of preterm labor drug to XOMA Corp
 urn:newsml:reuters.com:*:nL4N32I2BL
    ** Walgreens Boots Alliance Inc  WBA.O : up 1.2% premarket
    BUZZ - Rises as Cowen upgrades on healthcare services push  urn:newsml:reuters.com:*:nL4N32I2D7 
 (Compiled by Rajarshi Roy and Aditya Samal; Edited by Shilpi Majumdar)
 ((Rajarshi.Roy@thomsonreuters.com; Aditya.Samal@thomsonreuters.com))

Recent news on Gamida Cell

See all news